Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/1770
DC FieldValueLanguage
dc.contributor.authorLaurenti, Lucaen_US
dc.contributor.authorPetlickovski, Aleksandaren_US
dc.contributor.authorRumi, Carloen_US
dc.contributor.authorGobessi, Stefaniaen_US
dc.contributor.authorPiccioni, Paolaen_US
dc.contributor.authorTarnani, Michelaen_US
dc.contributor.authorPuggioni, Pierluigien_US
dc.contributor.authorMarietti, Saraen_US
dc.contributor.authorSica, Simonaen_US
dc.contributor.authorLeone, Giuseppeen_US
dc.contributor.authorEfremov, Dimitar Gen_US
dc.date.accessioned2019-03-21T11:41:24Z-
dc.date.available2019-03-21T11:41:24Z-
dc.date.issued2005-11-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/1770-
dc.description.abstractThe protein tyrosine kinase ZAP-70 has recently emerged as a major prognostic indicator in chronic lymphocytic leukemia (CLL). ZAP-70 is structurally and functionally homologous to Syk, a key mediator of B-cell receptor signaling. We therefore evaluated ZAP-70 expression in CLL B cells using Syk as an intracellular standard.en_US
dc.language.isoenen_US
dc.relation.ispartofHaematologicaen_US
dc.titleComparison of ZAP-70/Syk mRNA levels with immunoglobulin heavy-chain gene mutation status and disease progression in chronic lymphocytic leukemiaen_US
dc.typeArticleen_US
dc.identifier.volume90-
dc.identifier.issue11-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

131
checked on Apr 22, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.